0001879785-22-000062.txt : 20220822 0001879785-22-000062.hdr.sgml : 20220822 20220822153415 ACCESSION NUMBER: 0001879785-22-000062 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220822 DATE AS OF CHANGE: 20220822 EFFECTIVENESS DATE: 20220822 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Innervace, Inc. CENTRAL INDEX KEY: 0001941327 IRS NUMBER: 830564444 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-456567 FILM NUMBER: 221183665 BUSINESS ADDRESS: STREET 1: 345 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10010 BUSINESS PHONE: 202-352-7637 MAIL ADDRESS: STREET 1: 345 PARK AVENUE SOUTH CITY: NEW YORK STATE: NY ZIP: 10010 D 1 primary_doc.xml X0708 D LIVE 0001941327 Innervace, Inc. 345 PARK AVENUE SOUTH NEW YORK NY NEW YORK 10010 202-352-7637 DELAWARE None None Corporation true 2020 Nader Halim 345 Park Avenue South New York NY NEW YORK 10010 Executive Officer Director Althea Stillman 345 Park Avenue South New York NY NEW YORK 10010 Executive Officer Director Jonathan Leff 345 Park Avenue South New York NY NEW YORK 10010 Director David Greenwald 345 Park Avenue South New York NY NEW YORK 10010 Director Biotechnology Decline to Disclose 06b false 2022-08-08 false true false 0 40000000 9999973 30000027 false 7 0 0 0 false Innervace, Inc. /s/ Nader Halim Nader Halim CEO of the Issuer 2022-08-22